+1 (704) 266-3234

United States Prophylactic Human Vaccine Market Report & Forecast 2021-2027

Published on: Oct 2021 | From USD $3400 | Published By: QY RESEARCH | Number Of Pages: 90

United States Prophylactic Human Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Prophylactic Human Vaccine Market Segment Percentages, By Type, 2020 (%)
Inactivated Vaccine
Attenuated Vaccine
Others

United States Prophylactic Human Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Prophylactic Human Vaccine Market Segment Percentages, By Application, 2020 (%)
Hospital
Scientific Research
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prophylactic Human Vaccine revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Prophylactic Human Vaccine revenues share in United States market, 2020 (%)
Key companies Prophylactic Human Vaccine sales in United States market, 2016-2021 (Estimated), (K Units)
Key companies Prophylactic Human Vaccine sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Biovac
McKesson Medical
Merck
Merial
Zoetis
Sanofi

1 Introduction to Research & Analysis Reports
1.1 Prophylactic Human Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Prophylactic Human Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States Prophylactic Human Vaccine Overall Market Size
2.1 United States Prophylactic Human Vaccine Market Size: 2021 VS 2027
2.2 United States Prophylactic Human Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Prophylactic Human Vaccine Sales: 2016-2027

3 Company Landscape
3.1 Top Prophylactic Human Vaccine Players in United States Market
3.2 Top United States Prophylactic Human Vaccine Companies Ranked by Revenue
3.3 United States Prophylactic Human Vaccine Revenue by Companies
3.4 United States Prophylactic Human Vaccine Sales by Companies
3.5 United States Prophylactic Human Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Prophylactic Human Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Prophylactic Human Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prophylactic Human Vaccine Players in United States Market
3.8.1 List of Tier 1 Prophylactic Human Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Prophylactic Human Vaccine Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Prophylactic Human Vaccine Market Size Markets, 2021 & 2027
4.1.2 Inactivated Vaccine
4.1.3 Attenuated Vaccine
4.1.4 Others
4.2 By Type - United States Prophylactic Human Vaccine Revenue & Forecasts
4.2.1 By Type - United States Prophylactic Human Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Prophylactic Human Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Prophylactic Human Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Prophylactic Human Vaccine Sales & Forecasts
4.3.1 By Type - United States Prophylactic Human Vaccine Sales, 2016-2021
4.3.2 By Type - United States Prophylactic Human Vaccine Sales, 2022-2027
4.3.3 By Type - United States Prophylactic Human Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Prophylactic Human Vaccine Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Prophylactic Human Vaccine Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application - United States Prophylactic Human Vaccine Revenue & Forecasts
5.2.1 By Application - United States Prophylactic Human Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Prophylactic Human Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Prophylactic Human Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States Prophylactic Human Vaccine Sales & Forecasts
5.3.1 By Application - United States Prophylactic Human Vaccine Sales, 2016-2021
5.3.2 By Application - United States Prophylactic Human Vaccine Sales, 2022-2027
5.3.3 By Application - United States Prophylactic Human Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States Prophylactic Human Vaccine Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Overview
6.1.3 GSK Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 GSK Prophylactic Human Vaccine Product Description
6.1.5 GSK Recent Developments
6.2 Biovac
6.2.1 Biovac Corporation Information
6.2.2 Biovac Overview
6.2.3 Biovac Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 Biovac Prophylactic Human Vaccine Product Description
6.2.5 Biovac Recent Developments
6.3 McKesson Medical
6.3.1 McKesson Medical Corporation Information
6.3.2 McKesson Medical Overview
6.3.3 McKesson Medical Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 McKesson Medical Prophylactic Human Vaccine Product Description
6.3.5 McKesson Medical Recent Developments
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Overview
6.4.3 Merck Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 Merck Prophylactic Human Vaccine Product Description
6.4.5 Merck Recent Developments
6.5 Merial
6.5.1 Merial Corporation Information
6.5.2 Merial Overview
6.5.3 Merial Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 Merial Prophylactic Human Vaccine Product Description
6.5.5 Merial Recent Developments
6.6 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Overview
6.6.3 Zoetis Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 Zoetis Prophylactic Human Vaccine Product Description
6.6.5 Zoetis Recent Developments
6.7 Sanofi
6.7.1 Sanofi Corporation Information
6.7.2 Sanofi Overview
6.7.3 Sanofi Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.7.4 Sanofi Prophylactic Human Vaccine Product Description
6.7.5 Sanofi Recent Developments

7 United States Prophylactic Human Vaccine Production Capacity, Analysis
7.1 United States Prophylactic Human Vaccine Production Capacity, 2016-2027
7.2 Prophylactic Human Vaccine Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Prophylactic Human Vaccine Supply Chain Analysis
9.1 Prophylactic Human Vaccine Industry Value Chain
9.2 Prophylactic Human Vaccine Upstream Market
9.3 Prophylactic Human Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Prophylactic Human Vaccine Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

List of Tables
Table 1. Key Players of Prophylactic Human Vaccine in United States Market
Table 2. Top Prophylactic Human Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Prophylactic Human Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Prophylactic Human Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Prophylactic Human Vaccine Sales by Companies, (K Units), 2016-2021
Table 6. United States Prophylactic Human Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Prophylactic Human Vaccine Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Prophylactic Human Vaccine Product Type
Table 9. List of Tier 1 Prophylactic Human Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Prophylactic Human Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Inactivated Vaccine
Table 12. Major Manufacturers of Attenuated Vaccine
Table 13. By Type – United States Prophylactic Human Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Prophylactic Human Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Prophylactic Human Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Prophylactic Human Vaccine Sales (K Units), 2016-2021
Table 17. By Type - United States Prophylactic Human Vaccine Sales (K Units), 2022-2027
Table 18. By Application – United States Prophylactic Human Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Prophylactic Human Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Prophylactic Human Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Prophylactic Human Vaccine Sales (K Units), 2016-2021
Table 22. By Application - United States Prophylactic Human Vaccine Sales (K Units), 2022-2027
Table 23. GSK Corporation Information
Table 24. GSK Description and Major Businesses
Table 25. GSK Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. GSK Prophylactic Human Vaccine Product
Table 27. GSK Recent Developments
Table 28. Biovac Corporation Information
Table 29. Biovac Description and Major Businesses
Table 30. Biovac Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Biovac Prophylactic Human Vaccine Product
Table 32. Biovac Recent Developments
Table 33. McKesson Medical Corporation Information
Table 34. McKesson Medical Description and Major Businesses
Table 35. McKesson Medical Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. McKesson Medical Prophylactic Human Vaccine Product
Table 37. McKesson Medical Recent Developments
Table 38. Merck Corporation Information
Table 39. Merck Description and Major Businesses
Table 40. Merck Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Merck Prophylactic Human Vaccine Product
Table 42. Merck Recent Developments
Table 43. Merial Corporation Information
Table 44. Merial Description and Major Businesses
Table 45. Merial Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Merial Prophylactic Human Vaccine Product
Table 47. Merial Recent Developments
Table 48. Zoetis Corporation Information
Table 49. Zoetis Description and Major Businesses
Table 50. Zoetis Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Zoetis Prophylactic Human Vaccine Product
Table 52. Zoetis Recent Developments
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Major Businesses
Table 55. Sanofi Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Sanofi Prophylactic Human Vaccine Product
Table 57. Sanofi Recent Developments
Table 58. Prophylactic Human Vaccine Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 59. United States Prophylactic Human Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Prophylactic Human Vaccine Market Opportunities & Trends in United States Market
Table 61. Prophylactic Human Vaccine Market Drivers in United States Market
Table 62. Prophylactic Human Vaccine Market Restraints in United States Market
Table 63. Prophylactic Human Vaccine Raw Materials
Table 64. Prophylactic Human Vaccine Raw Materials Suppliers in United States Market
Table 65. Typical Prophylactic Human Vaccine Downstream
Table 66. Prophylactic Human Vaccine Downstream Clients in United States Market
Table 67. Prophylactic Human Vaccine Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Prophylactic Human Vaccine Product Picture
Figure 2. Prophylactic Human Vaccine Segment by Type
Figure 3. Prophylactic Human Vaccine Segment by Application
Figure 4. United States Prophylactic Human Vaccine Market Overview: 2020
Figure 5. United States Prophylactic Human Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Prophylactic Human Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Prophylactic Human Vaccine Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prophylactic Human Vaccine Revenue in 2020
Figure 9. Inactivated Vaccine Product Picture
Figure 10. Attenuated Vaccine Product Picture
Figure 11. Others Product Picture
Figure 12. By Type - United States Prophylactic Human Vaccine Sales Market Share, 2016-2027
Figure 13. By Type - United States Prophylactic Human Vaccine Revenue Market Share, 2016-2027
Figure 14. By Type - United States Prophylactic Human Vaccine Price (USD/Unit), 2016-2027
Figure 15. Hospital
Figure 16. Scientific Research
Figure 17. Others
Figure 18. By Application - United States Prophylactic Human Vaccine Sales Market Share, 2016-2027
Figure 19. By Application - United States Prophylactic Human Vaccine Revenue Market Share, 2016-2027
Figure 20. By Application - United States Prophylactic Human Vaccine Price (USD/Unit), 2016-2027
Figure 21. GSK Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Biovac Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. McKesson Medical Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Merck Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Merial Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Zoetis Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Sanofi Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. United States Prophylactic Human Vaccine Production Capacity (K Units), 2016-2027
Figure 29. Prophylactic Human Vaccine Industry Value Chain
Figure 30. Marketing Channels

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3400
USD $5100
USD $6800
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.